Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.5504 (3.65%) ($6.0800 - $6.6432) on Mon. Oct. 28, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.53% (three month average) | RSI | 57 | Latest Price | $6.5504(3.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.8% a day on average for past five trading days. | Weekly Trend | EYES advances 1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) IGOV(7%) UNG(7%) ICLN(5%) FIVG(4%) | Factors Impacting EYES price | EYES will decline at least -1.765% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.765% (StdDev 3.53%) | Hourly BBV | 0 () | Intraday Trend | 3.6% | | | |
|
Resistance Level | $6.58 | 5 Day Moving Average | $6.65(-1.5%) | 10 Day Moving Average | $6.67(-1.79%) | 20 Day Moving Average | $6.58(-0.45%) | To recent high | -14.7% | To recent low | 12.2% | Market Cap | $2.092b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |